v3.20.1
CONSOLIDATED BALANCE SHEETS - USD ($)
Dec. 31, 2019
Dec. 31, 2018
Current assets:    
Cash $ 12,108,582 $ 4,450,160
Inventory 577,690 0
Vendor deposits 0 100,000
Prepaid expenses 141,221 78,442
Total current assets 12,827,493 4,628,602
Property and equipment, net 180,368 44,346
Right-to-use assets, net 714,342 0
Other assets:    
Patents, net 364,536 268,796
Trademarks 1,125 850
Prepaid expenses, long term 27,410 0
Deposits 101,839 54,238
Total assets 14,217,113 4,996,832
Current liabilities:    
Accounts payable and accrued expenses, including $39,674 and $32,366 to related parties as of December 31, 2019 and 2018, respectively 1,488,776 954,655
Dividends payable 128,478 242,908
Lease liability, short term 412,288 0
Total current liabilities 2,029,542 1,197,563
Lease liability, long term 311,131 0
Total debt 2,340,673 1,197,563
Commitments and contingencies (Note 13)
Convertible Preferred Stock 215,000 475,000
Equity:    
Preferred stock 0 0
Common stock, $0.001 par value, authorized 200,000,000 shares, 23,323,087 and 16,868,783 issued and outstanding as of December 31, 2019 and 2018, respectively 23,323 16,869
Additional paid in capital 115,910,058 74,039,341
Accumulated deficit (104,786,769) (70,731,941)
Total stockholders' equity attributable to BioSig Technologies, Inc 11,146,612 3,324,269
Non-controlling interest 514,828 0
Total equity 11,661,440 3,324,269
Total liabilities and equity $ 14,217,113 $ 4,996,832

Source